Inmaculada Colina

1.4k total citations
32 papers, 1.1k citations indexed

About

Inmaculada Colina is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Physiology. According to data from OpenAlex, Inmaculada Colina has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 11 papers in Epidemiology and 8 papers in Physiology. Recurrent topics in Inmaculada Colina's work include Atherosclerosis and Cardiovascular Diseases (7 papers), Adipokines, Inflammation, and Metabolic Diseases (7 papers) and Cardiovascular Disease and Adiposity (6 papers). Inmaculada Colina is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (7 papers), Adipokines, Inflammation, and Metabolic Diseases (7 papers) and Cardiovascular Disease and Adiposity (6 papers). Inmaculada Colina collaborates with scholars based in Spain, United States and Italy. Inmaculada Colina's co-authors include Gema Frühbeck, Amaia Rodrı́guez, Javier Gómez‐Ambrosi, Victoria Catalán, Javier Salvador, Beatriz Ramírez, Sara Becerril, Camilo Silva, Marı́a J. Gil and Carmen Mugueta and has published in prestigious journals such as PLoS ONE, Hepatology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Inmaculada Colina

32 papers receiving 1.1k citations

Peers

Inmaculada Colina
Inmaculada Colina
Citations per year, relative to Inmaculada Colina Inmaculada Colina (= 1×) peers Dao‐Ming Chang

Countries citing papers authored by Inmaculada Colina

Since Specialization
Citations

This map shows the geographic impact of Inmaculada Colina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inmaculada Colina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inmaculada Colina more than expected).

Fields of papers citing papers by Inmaculada Colina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inmaculada Colina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inmaculada Colina. The network helps show where Inmaculada Colina may publish in the future.

Co-authorship network of co-authors of Inmaculada Colina

This figure shows the co-authorship network connecting the top 25 collaborators of Inmaculada Colina. A scholar is included among the top collaborators of Inmaculada Colina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inmaculada Colina. Inmaculada Colina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Becerril, Sara, Víctor Valentí, Rafael Moncada, et al.. (2024). FNDC4 reduces hepatocyte inflammatory cell death via AMPKα in metabolic dysfunction-associated steatotic liver disease. Clinical Nutrition. 43(9). 2221–2233. 8 indexed citations
2.
Perdomo, Carolina M., Nerea Martín‐Calvo, Ana Ezponda, et al.. (2024). Epicardial and liver fat implications in albuminuria: a retrospective study. Cardiovascular Diabetology. 23(1). 308–308. 1 indexed citations
3.
Colina, Inmaculada, Óscar Beloqui, J. Ignacio Monreal, et al.. (2024). Evaluation of measured and calculated small dense low-density lipoprotein in capillary blood and association with the metabolic syndrome. Clinica Chimica Acta. 557. 117897–117897. 2 indexed citations
4.
Becerril, Sara, Víctor Valentí, Rafael Moncada, et al.. (2023). Uroguanylin prevents hepatic steatosis, mitochondrial dysfunction and fibrosis in obesity-associated NAFLD. Metabolism. 147. 155663–155663. 15 indexed citations
5.
Orbe, Josune, Carmen Roncal, José Antonio Rodríguez, et al.. (2021). Association of SDF1 and MMP12 with Atherosclerosis and Inflammation: Clinical and Experimental Study. Life. 11(5). 414–414. 11 indexed citations
6.
Landecho, Manuel F., Jesús López–Fidalgo, Inmaculada Colina, et al.. (2020). Unravelling gender‐specific factors that link obesity to albuminuria. European Journal of Clinical Investigation. 50(11). e13307–e13307. 7 indexed citations
7.
González, Jessica, Pilar Rivera‐Ortega, Macarena Rodríguez‐Fraile, et al.. (2020). <p>Exploring the Association Between Emphysema Phenotypes and Low Bone Mineral Density in Smokers with and without COPD</p>. International Journal of COPD. Volume 15. 1823–1829. 1 indexed citations
8.
Frühbeck, Gema, Victoria Catalán, Amaia Rodrı́guez, et al.. (2019). Adiponectin-leptin Ratio is a Functional Biomarker of Adipose Tissue Inflammation. Nutrients. 11(2). 454–454. 180 indexed citations
9.
González, Jessica, Macarena Rodríguez‐Fraile, Pilar Rivera‐Ortega, et al.. (2019). Trabecular bone score in active or former smokers with and without COPD. PLoS ONE. 14(2). e0209777–e0209777. 8 indexed citations
10.
Landecho, Manuel F., et al.. (2018). Comparison of correlations of equation-derived body fat percentage and body mass index with carotid intima-media thickness. Acta Diabetologica. 56(3). 373–375. 3 indexed citations
11.
Gómez‐Ambrosi, Javier, Victoria Catalán, Amaia Rodrı́guez, et al.. (2017). Clinical usefulness of abdominal bioimpedance (ViScan) in the determination of visceral fat and its application in the diagnosis and management of obesity and its comorbidities. Clinical Nutrition. 37(2). 580–589. 55 indexed citations
12.
Frühbeck, Gema, Victoria Catalán, Amaia Rodrı́guez, et al.. (2017). Involvement of the leptin-adiponectin axis in inflammation and oxidative stress in the metabolic syndrome. Scientific Reports. 7(1). 6619–6619. 165 indexed citations
13.
Zagaceta, Jorge, Gorka Bastarrika, Javier J. Zulueta, et al.. (2017). Prospective comparison of non-invasive risk markers of major cardiovascular events in COPD patients. Respiratory Research. 18(1). 175–175. 22 indexed citations
14.
15.
Zagaceta, Jorge, Javier J. Zulueta, Gorka Bastarrika, et al.. (2013). Epicardial Adipose Tissue in Patients with Chronic Obstructive Pulmonary Disease. PLoS ONE. 8(6). e65593–e65593. 21 indexed citations
16.
Landecho, Manuel F., Inmaculada Colina, Ana E. Huerta, et al.. (2011). Relación entre las fases precoces de la enfermedad renal y el síndrome metabólico. Revista Española de Cardiología. 64(5). 373–378. 13 indexed citations
17.
Páramo, José A., Josune Orbe, Óscar Beloqui, et al.. (2008). Asociación de marcadores inflamatorios y aterosclerosis subclínica en relación con la edad en sujetos sin enfermedad cardiovascular. Medicina Clínica. 131(10). 361–365. 5 indexed citations
18.
Beloqui, Óscar, José A. Páramo, Josune Orbe, et al.. (2004). Monocyte cyclooxygenase-2 overactivity: a new marker of subclinical atherosclerosis in asymptomatic subjects with cardiovascular risk factors?. European Heart Journal. 26(2). 153–158. 37 indexed citations
19.
Martínez‐Vila, Eduardo, José A. Páramo, Óscar Beloqui, et al.. (2003). Independent Association of Fibrinogen with Carotid Intima-Media Thickness in Asymptomatic Subjects. Cerebrovascular Diseases. 16(4). 356–362. 27 indexed citations
20.
Casas, Josefina, J Roselló, Emilio Gelpı́, et al.. (1986). Determination of 2,3-dinor-6-ketoprostaglandin F1α in urine samples by liquid chromatography and radioimmunoassay. Journal of Chromatography B Biomedical Sciences and Applications. 383(2). 317–324. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026